Electrophysiology Mapping and Ablation Devices – Market Insights – United States

The US EP mapping and ablation device market will experience moderate growth through 2032, with trends varying by device segment. The COVID-19 pandemic had a significant impact on some EP ablation procedures in 2020, followed by a period of recovery. Growth in market revenues will be driven by increasing ablation procedure volumes and uptake of premium-priced devices. Innovations in this space will lead to improved outcomes and procedure growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in the US from 2019 through 2032.

Several new technologies are being introduced commercially, with more undergoing clinical trials.

Which technologies will enter the market going forward, and when are they expected to be launched?

How will the uptake of new devices affect pricing trends and revenue growth?

Which new competitors could enter the market? How are their technologies differentiated compared to devices available today?

What effect do and will innovative device types—like dual-energy catheters, PFA, and cryoablation—have on the overall market?

The generation of clinical data will be an important competitive factor for EP mapping and ablation devices.

What regulatory and reimbursement changes have occurred and are expected due to clinical evidence?

How has clinical data supported the use of AF ablations in expanding populations?

How will the market share dynamics of different device segments be altered by ongoing clinical trials?

Recent market developments and events in this space have had a significant impact in the EP mapping and ablation market.

What effect have mergers and acquisitions had on the market?

How will market share dynamics shift with recent events occurring in this space?

How will combining competitive efforts affect the landscape?

The changing landscape of AF treatment volumes is influencing EP ablation procedures.

How have reimbursement rates impacted the distribution of EP ablation procedures?

How does AF treatment volume growth compare to other arrhythmia types?

What level of adoption can be anticipated for various types of devices?

Table of contents